Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
martedì, ottobre 20
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
MiMedx Group Inc
MDXG
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$4.40
0.02
0.46%
Ult. Agg.: Oct 20, 8:36 AM
$4.40
0.02
0.46%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Utili:
I risultati di Q3 2026 tra 8 giorni da adesso in mer ott 28th, dopo la chiusura del mercato
MiMedx Group Financials
MiMedx Group (MDXG) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
MiMedx Group Affirms FY2026 Sales Guidance of $260.000M-$290.000M vs $269.440M Est
MiMedx Group (NASDAQ:MDXG) affirms FY2026 sales outlook from $260.000 million-$290.000 million to $260.000 million-$290.000 million vs $269.440 million estimate.
Benzinga Newsdesk
PRO
MiMedx Group Q2 Adj. EPS $(0.05), Inline, Sales $64.362M Beat $63.460M Estimate
MiMedx Group (NASDAQ:MDXG) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 150 percent decrease over earnings of $0.10 per share from the same period last year. The
Benzinga Newsdesk
PRO
CORRECTION: MiMedx Group Q1 Adj. EPS $(0.05) Misses $(0.03) Estimate, Sales $58.991M Miss $65.020M Estimate.
MiMedx Group (NASDAQ:MDXG) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.03) by 66.67 percent. This is a 183.33 percent decrease over earnings of $0.06 per share from
Benzinga Newsdesk
PRO
MiMedx Group Lowers FY2026 Sales Guidance from $340.000M-$360.000M to $260.000M-$290.000M vs $307.000M Est
MiMedx Group (NASDAQ:MDXG) lowers FY2026 sales outlook from $340.000 million-$360.000 million to $260.000 million-$290.000 million vs $307.000 million estimate.
Benzinga Newsdesk
Earnings Scheduled For April 29, 2026
Benzinga Insights
PRO
MiMedx Group Sees FY2026 Sales $340.000M-$360.000M vs $376.533M Est
MiMedx Group (NASDAQ:MDXG) sees FY2026 sales of $340.000 million-$360.000 million vs $376.533 million analyst estimate.
Benzinga Newsdesk
